Indivior Pharmaceuticals INDV
NASDAQ INDV
$36.59 -0.29 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Updated

Indivior Pharmaceuticals (INDV) recorded Receivables - Other of $2 million in Q4 2025, unchanged from $2 million a year earlier.

Analysis

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025) Analysis & Trends

  • Across earlier years, Receivables - Other came in at $2 million in FY2024 (+100.0%) and $1 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Indivior Pharmaceuticals 4.35 Bn 3.32 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.00 Mn
Dec 31, 2024 2.00 Mn
Dec 31, 2023 1.00 Mn
API Access

Indivior Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=INDV&period=max&api_key=YOUR_API_KEY